NFKB1 and neoplasm: It blocks NF-κB in the inflammatory tumor microenvironment which subsequently inihibits pro-inflammatory mediators like tumour necrosis factor α (TNF-α) and interleukin (ILs) and enzymes (COX1/2), resulting in the inhibition of tumor progression and metastasis.